Markus Dettenhofer

Markus Dettenhofer

Inst. Tec. Europa Central

Markus Dettenhofer, Ph.D. is the Executive Director of the Central European Institute of Technology (CEITEC). CEITEC is a scientific consortium of 6 universities and research institutes in Brno, Czech Republic, which has up to 550 scientists working in the fields of life sciences, advanced materials and technologies. Prior to joining CEITEC, Dr. Dettenhofer was Project Leader in pre-clinical development for viral vaccine and antibody discovery at Crucell (Johnson & Johnson). His previous work at Harvard Medical School was in the field of genetics and developmental biology, including studies on genes which control bone development and memory function. He led a study analyzing the development of the biomedical economy in Panama. His most recent work is on governance practices in higher education institutions and their contribution to performance. Dr. Dettenhofer was a visiting scholar at the Institut de Biologie Molécularie et Cellularie in Strasbourg, France, and is frequently a Visiting Scientist with the Joint Research Centre of European Commission. He received his Ph.D. from Johns Hopkins University, and a B.S. from UC Berkeley.